Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1987-08-18
1989-11-07
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514120, 514841, 514843, A61K 3113, A61K 31557, A61K 3166
Patent
active
048792853
ABSTRACT:
The in-vivo or in-vitro administration of platelet activating factor (PAF) or analogue enhances the viability of fertilized embryos and improves rates of implantation in the uterus. Conversely, reduction of PAF concentration by in-vivo administration of PAF-antagonists such as Iloprost or PAF antibodies, has a contraceptive effect; particularly when used in conjunction with a post-coital contraceptive such as estrogen or a prostaglandin.
REFERENCES:
patent: 3883304 (1975-05-01), Hamilton
patent: 4539332 (1985-09-01), Bifu et al.
patent: 4540709 (1985-09-01), Chang et al.
patent: 4543339 (1985-09-01), O'Neill
patent: 4610687 (1986-09-01), Fogwell
patent: 4619917 (1986-10-01), Lee et al.
patent: 4665096 (1987-05-01), Oraa et al.
patent: 4670426 (1987-06-01), Zor
patent: 4704462 (1987-11-01), Chang et al.
patent: 4734280 (1988-03-01), Braguet
Baulieu, Etienne-Emile, Contragestion by the Progesterone . . . Control Research in Reproduction vol. 19 No. 1 Jan. 1987, pp. 3-4.
Morris et al, Interception: The Use of Postovulatory Estrogens to Prevent Implantation, Am. J. Obstet. Gyn. Jan. 1, 1973, pp. 101-106.
Griffin Ronald W.
Royal North Shore Hospital and Area Health Service
LandOfFree
Fertility control does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fertility control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fertility control will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-83942